Explore

Trendline Trendline
Neuraptive Therapeutics Appoints New Leadership to Drive Commercialization Efforts

Neuraptive Therapeutics Appoints New Leadership to Drive Commercialization Efforts

Neuraptive Therapeutics Appoints New Leadership to Drive Commercialization Efforts
Trendline Trendline
AbCellera Appoints Dr. Victor Sandor to Board of Directors, Enhancing Antibody Discovery Efforts

AbCellera Appoints Dr. Victor Sandor to Board of Directors, Enhancing Antibody Discovery Efforts

AbCellera Appoints Dr. Victor Sandor to Board of Directors, Enhancing Antibody Discovery Efforts
Trendline Trendline
Soley Therapeutics Appoints Berthil Clasen as Chief Business Officer to Lead Strategic Growth

Soley Therapeutics Appoints Berthil Clasen as Chief Business Officer to Lead Strategic Growth

Soley Therapeutics Appoints Berthil Clasen as Chief Business Officer to Lead Strategic Growth
Trendline Trendline
AbCellera Appoints Dr. Victor Sandor to Board of Directors, Enhancing Leadership in Antibody Discovery

AbCellera Appoints Dr. Victor Sandor to Board of Directors, Enhancing Leadership in Antibody Discovery

AbCellera Appoints Dr. Victor Sandor to Board of Directors, Enhancing Leadership in Antibody Discovery
Trendline Trendline
Ionis Pharmaceuticals Appoints Ludwig Hantson to Board of Directors, Signaling Strategic Growth

Ionis Pharmaceuticals Appoints Ludwig Hantson to Board of Directors, Signaling Strategic Growth

Ionis Pharmaceuticals Appoints Ludwig Hantson to Board of Directors, Signaling Strategic Growth
Trendline Trendline
Ionis Pharmaceuticals Appoints Ludwig Hantson to Board of Directors

Ionis Pharmaceuticals Appoints Ludwig Hantson to Board of Directors

Ionis Pharmaceuticals Appoints Ludwig Hantson to Board of Directors
Trendline Trendline
AbCellera Appoints Dr. Victor Sandor to Board of Directors, Enhancing Leadership

AbCellera Appoints Dr. Victor Sandor to Board of Directors, Enhancing Leadership

AbCellera Appoints Dr. Victor Sandor to Board of Directors, Enhancing Leadership
Trendline Trendline
Decoy Therapeutics CEO to Discuss Antiviral Development at hVIVO Capital Markets Day

Decoy Therapeutics CEO to Discuss Antiviral Development at hVIVO Capital Markets Day

Decoy Therapeutics CEO to Discuss Antiviral Development at hVIVO Capital Markets Day
Trendline Trendline
IDEAYA Biosciences Announces $300 Million Public Offering to Fund Cancer Therapy Development

IDEAYA Biosciences Announces $300 Million Public Offering to Fund Cancer Therapy Development

IDEAYA Biosciences Announces $300 Million Public Offering to Fund Cancer Therapy Development
Trendline Trendline
Cibus Appoints Craig Wichner as CEO to Drive Growth and Innovation

Cibus Appoints Craig Wichner as CEO to Drive Growth and Innovation

Cibus Appoints Craig Wichner as CEO to Drive Growth and Innovation
Trendline Trendline
Novo Nordisk CEO Considers Expansion into Longevity and Aesthetics Amidst Market Challenges

Novo Nordisk CEO Considers Expansion into Longevity and Aesthetics Amidst Market Challenges

Novo Nordisk CEO Considers Expansion into Longevity and Aesthetics Amidst Market Challenges
Trendline Trendline
Abivax Faces Stock Volatility Amid Ulcerative Colitis Drug Trial Results

Abivax Faces Stock Volatility Amid Ulcerative Colitis Drug Trial Results

Abivax Faces Stock Volatility Amid Ulcerative Colitis Drug Trial Results